Companies
Molecular Devices
the integrated end-to-end microbial screening system (plating, streaking, picking, re-inoculation) with AI colony recognition, a Danaher company since 2017.
- Country
- United States
Commercial
Danaher company
QPix 420 / FLEX
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
| automation-robotics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $8.5M total funding | siliconvalleyjournals.com |
| Revenue | $190M annual revenue | siliconvalleyjournals.com |
| Certification | ISO 9001, ISO/IEC 17025, and California Green Business certified | moleculardevices.com |
| Regulatory approval | Compliant with FDA 21 CFR Part 11 and EU GMP Annex 11 requirements for electronic records/signatures | moleculardevices.com |
| Headquarters | San Jose, California, United States | lifesciences.danaher.com · danaher.com |
Independent sources: danaher.com · lifesciences.danaher.com · siliconvalleyjournals.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Colony picking robots | automation-robotics | Low | → |
| Plate readers for bioproduction | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.